XML 42 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
The Company (Details) (USD $)
3 Months Ended 6 Months Ended 6 Months Ended 6 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Segment
Jun. 30, 2013
Dec. 31, 2013
Jun. 30, 2014
Senior-Secured Credit Facilities [Member]
May 12, 2014
Senior-Secured Credit Facilities [Member]
Jun. 30, 2014
Revolving Credit Facility [Member]
May 12, 2014
Revolving Credit Facility [Member]
Jun. 30, 2014
Term Loan [Member]
May 12, 2014
Term Loan [Member]
Jun. 30, 2014
Minimum [Member]
Jun. 30, 2014
Minimum [Member]
Senior-Secured Credit Facilities [Member]
Eurodollar [Member]
Jun. 30, 2014
Maximum [Member]
Jun. 30, 2014
Maximum [Member]
Senior-Secured Credit Facilities [Member]
Eurodollar [Member]
Jun. 30, 2014
PhotoMedex, Inc. [Member]
Jun. 30, 2014
Radiancy, Inc. [Member]
Jun. 30, 2014
LCA Vision Inc [Member]
Business Acquisition [Line Items]                                    
Maximum borrowing capacity           $ 85,000,000 $ 85,000,000 $ 10,000,000 $ 10,000,000 $ 75,000,000 $ 75,000,000              
Term loan period                   4 years                
Effective interest rate (in hundredths)                         3.25%   4.50%      
Possible increase in interest (in hundredths)           2.00%                        
Effective date of merger                                   May 12, 2014
Percentage of ownership on reverse merger (in hundredths)                               20.00% 80.00%  
Number of operating units     4                              
Percentage of shares acquired by wholly-owned subsidiary (in hundredths)                                   100.00%
Revenue Recognition [Abstract]                                    
Number of distribution channels     2                              
Period of sales deferred     14 days                              
Patient Receivables and Allowance for Doubtful Accounts [Abstract]                                    
Minimum collection period of patient receivables     12 months                              
Maximum collection period of patient receivables     36 months                              
Bad debt expense, on patient receivables     111,000                              
Percentage of bad debt expenses on patient receivables (in hundredths)     1.00%                              
Finance and interest charges on patient receivables     113,000                              
Insurance Reserves [Abstract]                                    
Insurance reserves 6,111,000   6,111,000                              
Derivatives [Abstract]                                    
Balance of derivative instruments 118,000   118,000                              
Amount recognized as financing income 93,000   183,000                              
Notional amounts of foreign currency derivatives 5,200,000   5,200,000                              
Warranty on Product Sales [Line Items]                                    
Period of warranty on product sales                       1 year   2 years        
Extended period of warranty on domestic sale of laser equipment                       3 years   4 years        
Activity in warranty accrual [Roll Forward]                                    
Accrual at beginning of year     1,151,000 1,440,000                            
Additions charged to warranty expense     398,000 691,000                            
Expiring warranties     (116,000) (281,000)                            
Claims satisfied     (497,000) (655,000)                            
Total 936,000 1,195,000 936,000 1,195,000                            
Less: current portion (864,000) (1,117,000) (864,000) (1,117,000) (1,094,000)                          
Accrued long-term warranty $ 72,000 $ 78,000 $ 72,000 $ 78,000                            
Weighted-average number of common and common equivalent shares outstanding [Abstract]                                    
Basic number of common shares outstanding (in shares) 18,723,484 20,573,048 18,721,463 20,624,588                            
Dilutive effect of stock options and warrants (in shares) 0 460,301 0 460,301                            
Diluted number of common and common stock equivalent shares outstanding (in shares) 18,723,484 21,033,349 18,721,463 21,084,889                            
Common stock options and warrants excluded from computation of diluted earnings per share (in shares) 2,550,516 2,200,350 2,550,516 2,200,350